NxStage said its Medisystems in-center business has completed development of the new Streamline blood tubing sets for use on the B. Braun Dialog and Dialog Plus hemodialysis systems in the US.
The launch of Streamline for the B. Braun machines broadens our relationship and extends the value of our product portfolio to B. Braun’s Renal Therapies Division giving patients and providers greater access to NxStage’s high quality, value-added in-center offerings, said Jeffrey H. Burbank, president and chief executive officer of NxStage. Streamline’s ability to improve patient clearances and reduce cost is yet another example of NxStage’s ability to innovate and bring value in the form of both clinical benefits and operational savings.
We are pleased to broaden our relationship with NxStage by offering the unique Streamline technology to our dialysis customers, stated Samuel Amory, vice president, B. Braun Medical Renal Therapies Division. We look forward to leveraging Streamline’s benefits with our state-of-the-art Dialog hemodialysis system and growing our business with NxStage.
